Fang Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Fang Dai has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Bo Zhou
Lanzhou University 222 Tianshui Street S.
16 shared publications Qi Wang
State Key Laboratory of Applied Organic Chemistry, Lanzhou University, 222 Tianshui Street S., Lanzhou, Gansu, 730000, China
7 shared publicationsXiao-Rong Ren
State Key Laboratory of Natural Product Chemistry, Lanzhou University, 222 Tianshui Street S., Lanzhou, Gansu 730000, China; School of Chemistry and Chemical Engineering, Shaoxing University, 1077 Chengnan Avenue, Shaoxing, Zhejiang 312000, China
4 shared publicationsYa-Long Zheng
State Key Laboratory of Applied Organic Chemistry, Lanzhou University, 222 Tianshui Street S., 730000, Lanzhou, Gansu, China; Medicine College of Pingdingshan University, 467000, Pingdingshan, Henan, China
4 shared publicationsWei Tang
State Key Laboratory of Natural Product Chemistry, Lanzhou University, 222 Tianshui Street S., Lanzhou, Gansu 730000, China
3 shared publicationsXiao-Ling Jin
State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, Gansu 730000, China
3 shared publications
Latest Publications
- 14 January 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 170, 109505
Selectively and efficiently eliciting a ROS-dependent energy crisis within cancer cells through a mitochondria-targeted catechol-based diphenylhextriene
- 14 January 2026
- Published by Elsevier in Bioorganic Chemistry
- Vol. 170, 109505
Selectively and efficiently eliciting a ROS-dependent energy crisis within cancer cells through a mitochondria-targeted catechol-based diphenylhextriene
- 27 November 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 227, 27-41
Identification of tanshinone I as a natural Cu(II) ionophore
- 27 November 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 227, 27-41
Identification of tanshinone I as a natural Cu(II) ionophore
Developing a novel benzothiazole-based red-emitting probe for intravital imaging of superoxide anion
- 6 February 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 250, 115191
Tumor killing by a dietary curcumin mono-carbonyl analog that works as a selective ROS generator via TrxR inhibition
- 6 February 2023
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 250, 115191
Tumor killing by a dietary curcumin mono-carbonyl analog that works as a selective ROS generator via TrxR inhibition
- 14 December 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 194, 298-307
Engineering piperlongumine-inspired analogs as Nrf2-dependent neuroprotectors against oxidative damage by an electrophilicity-based strategy
- 14 December 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 194, 298-307
Engineering piperlongumine-inspired analogs as Nrf2-dependent neuroprotectors against oxidative damage by an electrophilicity-based strategy
- 1 September 2020
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 238, 118429
Rational design of an ESIPT-based fluorescent probe for selectively monitoring glutathione in live cells and zebrafish
- 1 September 2020
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 238, 118429
Rational design of an ESIPT-based fluorescent probe for selectively monitoring glutathione in live cells and zebrafish
- 10 July 2018
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 66 (30) , 7983-7994
Applying an Electrophilicity-Based Strategy to Develop a Novel Nrf2 Activator Inspired from Dietary [6]-Shogaol
Activation of nuclear factor erythroid-2-related factor 2 (Nrf2) is a crucial cellular defense mechanisms against oxidative stress, and also an effective means to decrease the risk of oxidative stress-related diseases including cancer. Thus, identifying novel Nrf2 activators is highly anticipated. Inspired from [6]-shogaol (6S), an active component of ginger, herein we developed a novel potent Nrf2 activator, (1E,4E)-1-(4-hydroxy-3-methoxyphenyl)-7- methylocta-1,4,6-trien-3-one (SA) by an electrophilicity-based strategy. Compared with the parent 6S, SA bearing a short but entirely conjugated unsaturated ketone chain manifested the improved electrophilicity and cytoprotection (cell viability for the 10 µM 6S- and SA-treated group being 48.9 ± 5.3% and 76.1 ± 3.2%, respectively) against tert-butylhydroperoxide (t-BHP)-induced cell death (cell viability for the t-BHP-stimulated group being 42.4 ± 0.4%) of HepG2. Mechanistic study uncovers that SA works as a potent Nrf2 activator by inducing Keap1 modification, inhibiting Nrf2 ubiquitylation and phosphorylating ERK in a Michael acceptor-dependent fashion. Taking 6S as an example, this works illustrates the feasibility and importance of applying an electrophilicity-based strategy to develop Nrf2 activators with dietary molecules as an inspiration due to their low toxicity and extraordinarily diverse chemical scaffolds.
- 10 July 2018
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 66 (30) , 7983-7994
Applying an Electrophilicity-Based Strategy to Develop a Novel Nrf2 Activator Inspired from Dietary [6]-Shogaol
Activation of nuclear factor erythroid-2-related factor 2 (Nrf2) is a crucial cellular defense mechanisms against oxidative stress, and also an effective means to decrease the risk of oxidative stress-related diseases including cancer. Thus, identifying novel Nrf2 activators is highly anticipated. Inspired from [6]-shogaol (6S), an active component of ginger, herein we developed a novel potent Nrf2 activator, (1E,4E)-1-(4-hydroxy-3-methoxyphenyl)-7- methylocta-1,4,6-trien-3-one (SA) by an electrophilicity-based strategy. Compared with the parent 6S, SA bearing a short but entirely conjugated unsaturated ketone chain manifested the improved electrophilicity and cytoprotection (cell viability for the 10 µM 6S- and SA-treated group being 48.9 ± 5.3% and 76.1 ± 3.2%, respectively) against tert-butylhydroperoxide (t-BHP)-induced cell death (cell viability for the t-BHP-stimulated group being 42.4 ± 0.4%) of HepG2. Mechanistic study uncovers that SA works as a potent Nrf2 activator by inducing Keap1 modification, inhibiting Nrf2 ubiquitylation and phosphorylating ERK in a Michael acceptor-dependent fashion. Taking 6S as an example, this works illustrates the feasibility and importance of applying an electrophilicity-based strategy to develop Nrf2 activators with dietary molecules as an inspiration due to their low toxicity and extraordinarily diverse chemical scaffolds.
- 1 July 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 134, 72-85
Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death
- 1 July 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 134, 72-85
Design, synthesis, and evaluation of curcumin derivatives as Nrf2 activators and cytoprotectors against oxidative death
- 28 August 2015
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 59 (12) , 2395-2406
Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- ando-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog
Scope Catechol moieties are commonly present in dietary natural products that exert cancer chemopreventive activity. While the oxidative conversion of catechols into their corresponding o-quinones is generally considered to contribute to their cancer chemopreventive effects, the mechanism of the intracellular conversion has not been fully elucidated. Methods and results Among resveratrol and its hydroxylated analogs examined, only 3,4-dihydroxy-trans-stilbene exerted cytoprotective effects against t-butylhydroperoxide-induced death of HepG2 cells. This resveratrol analog activated the nuclear factor erythroid-2-related factor 2 (Nrf2) pathway through stimulating phosphorylation of Akt and inducing keap1 modification, thereby resulting in its nuclear translocation and subsequent transcriptional induction of phase II detoxifying enzymes. Its cytoprotective effect through Nrf2 activation was largely abrogated by pretreatment of cells with DTT, a sulfhydryl-containing nucleophile, and neocuproine, a specific chelating agent for copper ions. Conclusion We identified 3,4-dihydroxy-trans-stilbene as a novel Nrf2 activator that is converted intracellularly into its corresponding o-quinone electrophile by copper ions. The copper-mediated oxidation was required for the Nrf2 activation, subsequent transcriptional induction of phase II detoxifying enzymes and ultimately for cytoprotection. The findings demonstrate a previously underrecognized role for intracellular copper ions in the cancer chemopreventive effects of catechol-containing dietary natural products.
- 28 August 2015
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 59 (12) , 2395-2406
Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- ando-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog
Scope Catechol moieties are commonly present in dietary natural products that exert cancer chemopreventive activity. While the oxidative conversion of catechols into their corresponding o-quinones is generally considered to contribute to their cancer chemopreventive effects, the mechanism of the intracellular conversion has not been fully elucidated. Methods and results Among resveratrol and its hydroxylated analogs examined, only 3,4-dihydroxy-trans-stilbene exerted cytoprotective effects against t-butylhydroperoxide-induced death of HepG2 cells. This resveratrol analog activated the nuclear factor erythroid-2-related factor 2 (Nrf2) pathway through stimulating phosphorylation of Akt and inducing keap1 modification, thereby resulting in its nuclear translocation and subsequent transcriptional induction of phase II detoxifying enzymes. Its cytoprotective effect through Nrf2 activation was largely abrogated by pretreatment of cells with DTT, a sulfhydryl-containing nucleophile, and neocuproine, a specific chelating agent for copper ions. Conclusion We identified 3,4-dihydroxy-trans-stilbene as a novel Nrf2 activator that is converted intracellularly into its corresponding o-quinone electrophile by copper ions. The copper-mediated oxidation was required for the Nrf2 activation, subsequent transcriptional induction of phase II detoxifying enzymes and ultimately for cytoprotection. The findings demonstrate a previously underrecognized role for intracellular copper ions in the cancer chemopreventive effects of catechol-containing dietary natural products.